AR100748A1 - Derivado de 2-acilaminotiazol o su sal - Google Patents
Derivado de 2-acilaminotiazol o su salInfo
- Publication number
- AR100748A1 AR100748A1 ARP150101792A ARP150101792A AR100748A1 AR 100748 A1 AR100748 A1 AR 100748A1 AR P150101792 A ARP150101792 A AR P150101792A AR P150101792 A ARP150101792 A AR P150101792A AR 100748 A1 AR100748 A1 AR 100748A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- dysfunction
- salt
- compound
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 230000004064 dysfunction Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Se proporciona un compuesto el cual es útil como un ingrediente activo para una composición farmacéutica para prevenir o tratar la disfunción en el almacenamiento de orina, disfunción en la evacuación, disfunción del tracto urinario inferior, y similares. Reivindicación 1: Un compuesto de la fórmula (1) o una sal del mismo, (donde R¹ es -N(-R¹¹)(-R¹²), o amino cíclico el cual puede ser sustituido; R¹¹ es alquilo C₁₋₆; R¹² es alquilo C₁₋₆ el cual puede ser sustituido, o cicloalquilo C₃₋₈ el cual puede ser sustituido; R² es arilo el cual puede ser sustituido, anillo hetero aromático monocíclico el cual puede ser sustituido, o anillo hetero aromático bicíclico el cual puede ser sustituido; R³s son iguales o diferentes entre sí, y cada uno es alquilo C₁₋₆; W es alquileno C₁₋₆; y n es un número entero de 0 a 4).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014118046 | 2014-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR100748A1 true AR100748A1 (es) | 2016-10-26 |
Family
ID=54766887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150101792A AR100748A1 (es) | 2014-06-06 | 2015-06-05 | Derivado de 2-acilaminotiazol o su sal |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US9951060B2 (es) |
| EP (1) | EP3153511B1 (es) |
| JP (1) | JP6319436B2 (es) |
| KR (1) | KR102482844B1 (es) |
| CN (2) | CN106414438B (es) |
| AR (1) | AR100748A1 (es) |
| AU (1) | AU2015269449B2 (es) |
| BR (1) | BR112016028270B1 (es) |
| CA (1) | CA2950564C (es) |
| CO (1) | CO2017000044A2 (es) |
| CY (1) | CY1122290T1 (es) |
| DK (1) | DK3153511T3 (es) |
| EA (1) | EA031866B1 (es) |
| ES (1) | ES2732066T3 (es) |
| HR (1) | HRP20190943T1 (es) |
| HU (1) | HUE043496T2 (es) |
| IL (1) | IL249356B (es) |
| LT (1) | LT3153511T (es) |
| MA (1) | MA39950B1 (es) |
| ME (1) | ME03438B (es) |
| MX (2) | MX370140B (es) |
| MY (1) | MY197712A (es) |
| NZ (1) | NZ727142A (es) |
| PH (1) | PH12016502405B1 (es) |
| PL (1) | PL3153511T3 (es) |
| PT (1) | PT3153511T (es) |
| RS (1) | RS58809B1 (es) |
| SA (1) | SA516380427B1 (es) |
| SG (2) | SG11201610201UA (es) |
| SI (1) | SI3153511T1 (es) |
| SM (1) | SMT201900352T1 (es) |
| TR (1) | TR201908676T4 (es) |
| TW (2) | TWI689507B (es) |
| UA (1) | UA122208C2 (es) |
| WO (1) | WO2015186821A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4886041B2 (ja) | 2006-12-20 | 2012-02-29 | ジーブイビービー ホールディングス エス．エイ．アール．エル． | 埋め込みオーディオ・ルーティング切換器 |
| CN106573928B (zh) | 2014-08-26 | 2020-04-14 | 安斯泰来制药株式会社 | 2-氨基噻唑衍生物或其盐 |
| SI3555048T1 (sl) | 2016-12-19 | 2021-11-30 | Novartis Ag | Novi derivati pikolinske kisline in njihova uporaba kot vmesne spojine |
| JPWO2019189766A1 (ja) * | 2018-03-30 | 2021-04-08 | 持田製薬株式会社 | 新規ビアリールアミド誘導体 |
| CA3099655A1 (en) | 2018-05-08 | 2019-11-14 | Nippon Shinyaku Co., Ltd. | Azabenzimidazole compounds and pharmaceutical |
| CN111718293A (zh) * | 2019-03-18 | 2020-09-29 | 持田制药株式会社 | 双芳基酰胺衍生物的制造方法 |
| KR20220100627A (ko) | 2019-11-13 | 2022-07-15 | 니뽄 신야쿠 가부시키가이샤 | 아자벤즈이미다졸 화합물 및 의약 |
| EP3967311A1 (en) | 2020-09-11 | 2022-03-16 | Astellas Pharma Inc. | Compounds for use in the treatment of dry mouth |
| JPWO2024122076A1 (es) | 2022-12-09 | 2024-06-13 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73543C2 (uk) | 1999-12-07 | 2005-08-15 | Тераванс, Інк. | Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором |
| JP2001278872A (ja) * | 2000-03-27 | 2001-10-10 | Banyu Pharmaceut Co Ltd | 新規アミノチアゾール誘導体 |
| HRP20020904A2 (en) * | 2000-05-25 | 2004-12-31 | Hoffmann La Roche | Substituted 1-aminoalkyil-lactams and their use as muscarinic receptor antagonists |
| JPWO2003037862A1 (ja) * | 2001-10-30 | 2005-02-17 | 日本新薬株式会社 | アミド誘導体及び医薬 |
| DK1466912T3 (da) | 2002-01-18 | 2013-07-01 | Astellas Pharma Inc | 2-acylaminothiazolderivat eller salt deraf |
| TWI242478B (en) | 2002-08-01 | 2005-11-01 | Masami Nakamoto | Metal nanoparticle and process for producing the same |
| UY27927A1 (es) * | 2002-08-06 | 2003-12-31 | Glaxo Group Ltd | Antagonistas del receptor muscarínico m3 de acetilcolina |
| MXPA06000441A (es) | 2003-07-17 | 2006-04-05 | Astellas Pharma Inc | Derivado de 2-acilaminotiazole o sal del mismo. |
| JP4665769B2 (ja) | 2005-01-12 | 2011-04-06 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体の製造法 |
| JP4774995B2 (ja) | 2005-01-12 | 2011-09-21 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体を有効成分とする医薬組成物 |
| CN101490003A (zh) * | 2006-04-24 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | 具有毒蕈碱m3受体拮抗剂活性、用于治疗入慢性支气管阻塞、哮喘和膀胱过动的新型环状氨基醇的取代烷基酯类化合物 |
| KR101504787B1 (ko) | 2007-10-24 | 2015-03-20 | 아스테라스 세이야쿠 가부시키가이샤 | 아졸카복사마이드 화합물 또는 그 염 |
| KR101764952B1 (ko) | 2010-07-29 | 2017-08-03 | 리겔 파마슈티칼스, 인크. | Ａｍｐｋ-활성화 헤테로시클릭 화합물 및 그의 사용 방법 |
| TWI647227B (zh) | 2013-02-28 | 2019-01-11 | 日商安斯泰來製藥股份有限公司 | ２－醯胺噻唑衍生物或其鹽 |
-
2015
- 2015-06-05 HU HUE15803484A patent/HUE043496T2/hu unknown
- 2015-06-05 DK DK15803484.3T patent/DK3153511T3/da active
- 2015-06-05 CN CN201580030154.8A patent/CN106414438B/zh active Active
- 2015-06-05 EA EA201692469A patent/EA031866B1/ru not_active IP Right Cessation
- 2015-06-05 TR TR2019/08676T patent/TR201908676T4/tr unknown
- 2015-06-05 ES ES15803484T patent/ES2732066T3/es active Active
- 2015-06-05 CN CN201911226515.2A patent/CN110845490B/zh active Active
- 2015-06-05 EP EP15803484.3A patent/EP3153511B1/en active Active
- 2015-06-05 SG SG11201610201UA patent/SG11201610201UA/en unknown
- 2015-06-05 CA CA2950564A patent/CA2950564C/en active Active
- 2015-06-05 LT LTEP15803484.3T patent/LT3153511T/lt unknown
- 2015-06-05 UA UAA201700205A patent/UA122208C2/uk unknown
- 2015-06-05 SI SI201530787T patent/SI3153511T1/sl unknown
- 2015-06-05 TW TW104118315A patent/TWI689507B/zh active
- 2015-06-05 RS RS20190710A patent/RS58809B1/sr unknown
- 2015-06-05 SM SM20190352T patent/SMT201900352T1/it unknown
- 2015-06-05 US US15/316,645 patent/US9951060B2/en not_active Ceased
- 2015-06-05 SG SG10202000463YA patent/SG10202000463YA/en unknown
- 2015-06-05 AR ARP150101792A patent/AR100748A1/es active IP Right Grant
- 2015-06-05 KR KR1020177000217A patent/KR102482844B1/ko active Active
- 2015-06-05 MA MA39950A patent/MA39950B1/fr unknown
- 2015-06-05 AU AU2015269449A patent/AU2015269449B2/en active Active
- 2015-06-05 PL PL15803484T patent/PL3153511T3/pl unknown
- 2015-06-05 PT PT15803484T patent/PT3153511T/pt unknown
- 2015-06-05 ME MEP-2019-163A patent/ME03438B/me unknown
- 2015-06-05 WO PCT/JP2015/066321 patent/WO2015186821A1/ja not_active Ceased
- 2015-06-05 BR BR112016028270-1A patent/BR112016028270B1/pt active IP Right Grant
- 2015-06-05 HR HRP20190943TT patent/HRP20190943T1/hr unknown
- 2015-06-05 TW TW109106548A patent/TWI745877B/zh active
- 2015-06-05 MX MX2016016134A patent/MX370140B/es active IP Right Grant
- 2015-06-05 US US16/856,738 patent/USRE49111E1/en active Active
- 2015-06-05 NZ NZ727142A patent/NZ727142A/en unknown
- 2015-06-05 MX MX2019014490A patent/MX387775B/es unknown
- 2015-06-05 JP JP2016525246A patent/JP6319436B2/ja active Active
- 2015-06-05 MY MYPI2016704529A patent/MY197712A/en unknown
-
2016
- 2016-12-02 PH PH12016502405A patent/PH12016502405B1/en unknown
- 2016-12-04 IL IL24935616A patent/IL249356B/en active IP Right Grant
- 2016-12-05 SA SA516380427A patent/SA516380427B1/ar unknown
-
2017
- 2017-01-04 CO CONC2017/0000044A patent/CO2017000044A2/es unknown
-
2019
- 2019-06-19 CY CY20191100631T patent/CY1122290T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR100748A1 (es) | Derivado de 2-acilaminotiazol o su sal | |
| AR094921A1 (es) | Derivados de 2-acilaminotiazol o su sal | |
| UY34649A (es) | Compuestos heterobicíclicos | |
| DOP2017000149A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
| UA122781C2 (uk) | Пестицидно активні гетероциклічні похідні з сірковмісними замісниками | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| MX380691B (es) | Derivados policiclicos activos como plaguicidas con sustituyentes que contienen azufre. | |
| MX380777B (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7. | |
| DOP2018000196A (es) | Metodos para tratar la depresion con antagonistas del receptor de orexina-2 | |
| CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
| MX2019009185A (es) | Compuesto heterociclico novedoso, su metodo de preparacion y composicion farmaceutica que lo comprende. | |
| MX391489B (es) | Inhibidores heterociclicos de mct4. | |
| UY36118A (es) | Compuestos y composiciones para inducir condrogénesis | |
| EA201692542A1 (ru) | Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы | |
| UY36373A (es) | Compuestos para usarse en el tratamiento antihelmíntico | |
| AR101290A1 (es) | Inhibidores de aldosterona sintasa | |
| MX2017006709A (es) | Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales. | |
| MX376887B (es) | Separadores para implantes mamarios para el tratamiento de infecciones periprosteticas de los implantes mamarios. | |
| MX387920B (es) | Peptidos antagonistas de prgc. | |
| AR107164A1 (es) | INHIBIDORES DE QUINASA p38 | |
| AR100870A1 (es) | Repelente de animales roedores | |
| AR099208A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
| UA115714U (xx) | Засіб із гепатопротекторною та спермомодулюючою дією у формі капсул | |
| UA91125U (uk) | Антибактеріальна композиція |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |